好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Frequency of Seizures and Epilepsy in Familial Dysautonomia
Neuromuscular and Clinical Neurophysiology (EMG)
P3 - Poster Session 3 (5:30 PM-6:30 PM)
7-061

To determine the frequency of epilepsy and seizures in patients with familial dysautonomia (FD, hereditary sensory autonomic neuropathy III).

Patients with FD have frequent paroxysmal episodes concerning for seizure. The differential diagnosis of these episodes is ample and includes autonomic crisis, hypoxia, and hypotension. Our aim was to categorize the EEG results and the frequency of epileptiform activity in a large sample of patients with genetically confirmed FD.

Retrospective chart review of all cases with FD documented in the New York University FD Patient Registry, which includes virtually every patient diagnosed with FD. We used the search terms “EEG”, “epilepsy”, and “seizure.”

Out of 676 subjects documented in the NYU FD Patient Registry, we identified 399 adult and pediatric patients that had diagnostic tests (EEG, polysomnography) performed for possible seizure events between 1951 and 2018. Of these, 147 (36.8 %) patients had normal findings and 121 (30.3 %) had epileptiform EEG patterns. Non-epileptiform EEG findings including generalized or focal slowing or generalized or focal cerebral dysfunction, were present in 74 (18.5 %) patients. Forty patients (10%) had nonspecific results and 6 (1%) had beta activity possibly related to benzodiazepines.

Approximately 1 in 3 patients with FD and paroxysmal episodes have findings consistent with epileptiform activity on EEG. Epileptiform findings appear to be relatively common in FD and should be considered in the differential diagnosis of paroxysmal episodes.
Authors/Disclosures
Bhumika Balgobin, MD (NYU Langone Ambulatory Care East Meadow)
PRESENTER
No disclosure on file
Jose-Alberto Palma, MD, PhD, FAAN (New York University Grossman School of Medicine) Dr. Palma has received personal compensation for serving as an employee of Eli Lilly. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care.
No disclosure on file
Horacio C. Kaufmann, MD, FAAN (NYU Langone Health - NYU Dysautonomia Center) Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.